African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2288

Full Length Research Paper

Do HIV infection and antiretroviral therapy influence multidrug-resistant tuberculosis treatment outcomes?

Mugabo, P.*
  • Mugabo, P.*
  • Department of Pharmacy, Discipline of Pharmacology, University of the Western Cape, Private Bag X 17, Bellville, 7535, Cape Town , South Africa
  • Google Scholar
Adewumi, A.O.
  • Adewumi, A.O.
  • Department of Pharmacy, Discipline of Pharmacology, University of the Western Cape, Private Bag X 17, Bellville, 7535, Cape Town , South Africa
  • Google Scholar
Theron, D.
  • Theron, D.
  • Department of Health, Western Cape Province, Brewelskloof Hospital, Worcester, South Africa.
  • Google Scholar
Burger, A.
  • Burger, A.
  • Department of Health, Western Cape Province, Brewelskloof Hospital, Worcester, South Africa.
  • Google Scholar
Van, Zyl L.
  • Van, Zyl L.
  • Department of Health, Western Cape Province, Brewelskloof Hospital, Worcester, South Africa.
  • Google Scholar


  •  Received: 21 February 2015
  •  Accepted: 01 July 2015
  •  Published: 22 September 2015

References

Department of Health (2013). Management of Drug-resistant Tuberculosis. Draft Policy Guidelines. National Tuberculosis Programme. (3nd ed).
 
Department of Health, Republic of South Africa (2011). Management of
 
Finlay A, Lancaster J, Holtz TH, Weyer K, Miranda A, van der Walt M (2012). Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study. BMC Public Health 12:56.
Crossref
 
Holtz TH, Lancaster J, Laserson KF, Wells CD, Thorpe L, Weyer K. (2006). Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001. Int. J. Tuberc. Lung Dis. 10(6):649-55.
 
Kim DH, Kim HJ, Park SK, Kong SJ, Kim YS, Kim TH, Kim EK, Lee KM, Lee SS, Park JS, KOH WJ, Lee CH, Shim TS (2010). Treatment outcomes and survival based on drug resistance patterns in multi drug-resistant tuberculosis. Am. J. Respir. Crit. Care Med. 182:113-119.
Crossref
 
Kumar V, Abbas AK, Nelson F, Mitchell RN (2007). Robbins Basic Pathology (8th ed.). Saunders Elsevier pp. 516-522.
 
Meintjes G (2014). Management of drug-resistant TB in patients with HIV co-infection. Abstracts of the HIV Drug Therapy Glasgow Congress 2014. J. Int. AIDS Soc. 17(Suppl 3):19508.
 
Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, Hollo V, Jaramillo E, Leimane V, Mitnick CD, Mukherjee JS, Nunn P, Pasechnikov A, Tupasi T, Wells C, Raviglione MC (2006). Multidrug-resistant tuberculosis management in resource-limited settings. Emerg. Infect. Dis. 12(9):1389-1397.
Crossref
 
Pepper DJ, Rebe K, Morroni C, Wilkinson RJ, Meintjes G (2009). Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses. PLoS ONE 4(2):e4520.
Crossref
 
Sanchez-Padila E, Dlamini T, Ascorra A, Rusch – Gerdes S, Tefera ZD, Calain P, de la Tour R, Jochims F, Richter E, Bonnet M (2012). High Prevalence of Multidrug-resistant Tuberculosis, Swaziland, 2009-2010. J. Emerg. Infect. Dis. 18(1):29-37.
Crossref
 
Shean KP, Willcox PA, Siwendu SN, Laserson KF, Gross L, Kammerer S, Wells CD, Holtz TH (2008). Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992-2002. Int. J. Tuberc. Lung Dis. 12(10):1182-1189
 
Statistics South Africa (2014). Mortality and causes of death in South Africa, 2013: Findings from death notifications (Statistical Release P0309.3).Available at: www.statssa.goz.za.
 
Theron D (2003-2005). Boland/Overberg region, MDR Outcomes 2003-2005, unpublished observations. Brewelskloof Hospital 2003, 2004, 2005 Annual report.
 
World Health Organization (2009). Global Tuberculosis Control: Epidemiology, Strategy, Financing. WHO Report 2009. ISBN 98 92 4 156380 2. World Health Organization, Geneva, Switzerland.